Lallemand launches Cerebiome to support stress by way of gut-brain axis

July 3, 2020

Previously known as Probio’Stick, Lallemand’s Cerebiome showcases the product’s effect on the gut-brain axis, referring to it as a “psychobiotic.”

Lallemand Health Solutions (Mirabel, Canada) has rebranded an existing formula consisting of Lactobacillus helveticus Rosell-52 and Bifidobacterium longum Rosell-175 to Cerebiome. Previously known as Probio’Stick, Lallemand’s Cerebiome showcases the product’s effect on the gut-brain axis, referring to it as a “psychobiotic.”

“Cerebiome is a unique and strongly documented psychobiotic formulation developed by the Rosell Institute for Microbiome and Probiotics by Lallemand,” explains Lucie Lingrand, Product Manager at Lallemand Health Solutions, in a press release. “It is the most documented psychobiotic with five clinical studies and several pre-clinical studies allowing to highlight eight mechanisms of action on the brain-gut axis. Cerebiome helps alleviate the physical and psychological symptoms of stress and feelings of anxiety. Such consistency of results is rare in this innovative field.”